658 related articles for article (PubMed ID: 8232225)
1. Beta-[3H]funaltrexamine-labeled mu-opioid receptors: species variations in molecular mass and glycosylation by complex-type, N-linked oligosaccharides.
Liu-Chen LY; Chen C; Phillips CA
Mol Pharmacol; 1993 Oct; 44(4):749-56. PubMed ID: 8232225
[TBL] [Abstract][Full Text] [Related]
2. Covalent labeling of mu opioid binding site by [3H]beta-funaltrexamine.
Liu-Chen LY; Phillips CA
Mol Pharmacol; 1987 Sep; 32(3):321-9. PubMed ID: 2823089
[TBL] [Abstract][Full Text] [Related]
3. Effect of intracerebroventricular beta-funaltrexamine on mu opioid receptors in the rat brain: consideration of binding condition.
Liu-Chen LY; Yang HH; Li S; Adams JU
J Pharmacol Exp Ther; 1995 Jun; 273(3):1047-56. PubMed ID: 7791074
[TBL] [Abstract][Full Text] [Related]
4. Studies on kinetics of [3H]beta-funaltrexamine binding to mu opioid receptor.
Liu-Chen LY; Li SX; Tallarida RJ
Mol Pharmacol; 1990 Feb; 37(2):243-50. PubMed ID: 2154672
[TBL] [Abstract][Full Text] [Related]
5. Reversible and irreversible binding of beta-funaltrexamine to mu, delta and kappa opioid receptors in guinea pig brain membranes.
Tam SW; Liu-Chen LY
J Pharmacol Exp Ther; 1986 Nov; 239(2):351-7. PubMed ID: 3021954
[TBL] [Abstract][Full Text] [Related]
6. Glycosylation of the mammalian alpha 1-adrenergic receptor by complex type N-linked oligosaccharides.
Sawutz DG; Lanier SM; Warren CD; Graham RM
Mol Pharmacol; 1987 Nov; 32(5):565-71. PubMed ID: 2824978
[TBL] [Abstract][Full Text] [Related]
7. Characterization of irreversible binding of beta-funaltrexamine to the cloned rat mu opioid receptor.
Chen C; Xue JC; Zhu J; Chen YW; Kunapuli S; Kim de Riel J; Yu L; Liu-Chen LY
J Biol Chem; 1995 Jul; 270(30):17866-70. PubMed ID: 7629089
[TBL] [Abstract][Full Text] [Related]
8. Cross-linking of human [125I]beta-endorphin to opioid receptors in rat striatal membranes: biochemical evidence for the existence of a mu/delta opioid receptor complex.
Schoffelmeer AN; Yao YH; Gioannini TL; Hiller JM; Ofri D; Roques BP; Simon EJ
J Pharmacol Exp Ther; 1990 Apr; 253(1):419-26. PubMed ID: 2158552
[TBL] [Abstract][Full Text] [Related]
9. Interaction of beta-funaltrexamine with [3H]cycloFOXY binding in rat brain: further evidence that beta-FNA alkylates the opioid receptor complex.
Rothman RB; Bykov V; Mahboubi A; Long JB; Jiang Q; Porreca F; de Costa BR; Jacobson AE; Rice KC; Holaday JW
Synapse; 1991 Jun; 8(2):86-99. PubMed ID: 1652797
[TBL] [Abstract][Full Text] [Related]
10. Glycoprotein nature of dopamine D1 receptors in the brain and parathyroid gland.
Jarvie KR; Booth G; Brown EM; Niznik HB
Mol Pharmacol; 1989 Oct; 36(4):566-74. PubMed ID: 2682204
[TBL] [Abstract][Full Text] [Related]
11. Affinity labeling of mu and kappa receptors with naloxone benzoylhydrazone.
Standifer KM; Murthy LR; Kinouchi K; Steele L; Pasternak GW
Mol Pharmacol; 1991 Mar; 39(3):290-8. PubMed ID: 1848652
[TBL] [Abstract][Full Text] [Related]
12. The E3-20.5K membrane protein of subgroup B human adenoviruses contains O-linked and complex N-linked oligosaccharides.
Hawkins LK; Wold WS
Virology; 1995 Jul; 210(2):335-44. PubMed ID: 7618271
[TBL] [Abstract][Full Text] [Related]
13. Alkylation of mu opioid receptors by beta-funaltrexamine in vivo: comparison of the effects on in situ binding and heroin self-administration in rats.
Martin TJ; Dworkin SI; Smith JE
J Pharmacol Exp Ther; 1995 Mar; 272(3):1135-40. PubMed ID: 7891326
[TBL] [Abstract][Full Text] [Related]
14. Regional difference in brain benzodiazepine receptor carbohydrates.
Sweetnam PM; Tallman JF
Mol Pharmacol; 1986 Mar; 29(3):299-306. PubMed ID: 3005837
[TBL] [Abstract][Full Text] [Related]
15. Dopamine D2 receptor binding subunits of Mr congruent to 140,000 and 94,000 in brain: deglycosylation yields a common unit of Mr congruent to 44,000.
Jarvie KR; Niznik HB; Seeman P
Mol Pharmacol; 1988 Aug; 34(2):91-7. PubMed ID: 2970586
[TBL] [Abstract][Full Text] [Related]
16. Solubilization and preliminary characterization of mu and kappa opiate receptor subtypes from rat brain.
Chow T; Zukin RS
Mol Pharmacol; 1983 Sep; 24(2):203-12. PubMed ID: 6310362
[TBL] [Abstract][Full Text] [Related]
17. Structural determination of N-linked carbohydrates by matrix-assisted laser desorption/ionization-mass spectrometry following enzymatic release within sodium dodecyl sulphate-polyacrylamide electrophoresis gels: application to species-specific glycosylation of alpha1-acid glycoprotein.
Küster B; Hunter AP; Wheeler SF; Dwek RA; Harvey DJ
Electrophoresis; 1998 Aug; 19(11):1950-9. PubMed ID: 9740055
[TBL] [Abstract][Full Text] [Related]
18. Affinity labeling of the mu opioid receptor in bovine striatal membranes with [3H]-14 beta-(bromoacetamido)-7,8-dihydromorphine.
Bidlack JM; Kaplan RA; Subbramanian RA; Seyed-Mozaffari A; Archer S
Biochemistry; 1993 Jul; 32(26):6703-11. PubMed ID: 7687147
[TBL] [Abstract][Full Text] [Related]
19. Determination of the amino acid residue involved in [3H]beta-funaltrexamine covalent binding in the cloned rat mu-opioid receptor.
Chen C; Yin J; Riel JK; DesJarlais RL; Raveglia LF; Zhu J; Liu-Chen LY
J Biol Chem; 1996 Aug; 271(35):21422-9. PubMed ID: 8702924
[TBL] [Abstract][Full Text] [Related]
20. Photoaffinity labeling of opiate receptors with 3H-etorphine: possible species differences in glycosylation.
Bowen WD; Kooper G
NIDA Res Monogr; 1986; 75():17-20. PubMed ID: 2828966
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
